Summary: An evaluation of an enzyme immunoassay for the determination of theophylline in serum (EMIT, Syva Corp.) is presented. The EMIT assay was fully mechanized by the use of an Eppendorf analyzer 5010. The precision of this enzyme immunoassay was satisfactory (coefficients of variation from day to day ranged from 5-6%). The EMIT assay proved to be specific, rapid and easy to perform. A comparison of the results obtained by EMIT and ultraviolet spectrophotometry in a series of 100 patients showed a good correlation between both methods.
Introduction
There is an increasing demand for rapid and reliable assays for the determination of serum levels of drugs, which have a narrow therapeutic range, and/or dangerous side effects, and for which considerable differences of pharmacokinetics between individuals are well documented. Enzyme immunoassays have proved useful for routine monitoring of serum levels of various antiepileptic drugs and digoxin, and have recently gained increasing importance (1, 2) .
Theophylline has been used for many years in the treatment of asthma (3) and for treating apnoea in premature infants (4) . It has been demonstrated recently that the dosage of theophylline, based on ä widely used body weight-derived formula (5) , is unreliable and can be dangerous (6, 7) , as there is a wide variation in the rate of metabolism of this compound (8) . Patients with hepatic disease such as liver cirrhosis, show a slow and variable metabolism of theophylline, as about ninety percent of this drug is metabolized in the liver (9) . Deaths from toxic theophylline concentrations have been observed with patients receiving therapeutic doses of the drug (10) . The early detection of theophylline overdosage by Clinical symptoms, however, may often be difficult, because typical signs like tachycardia or nausea are usually present in patients with respiratory distress due to the underlying disease. Furthermore, patients with toxic theophylline levels may develop seizures without preceding adverse effects (10) . Monitoring of serum theophylline levels has therefore been increasingly recommended in recent years (7, (11) (12) (13) (14) (15) . Usually, serum levels of theophylline between 10 and 20 mg/1 provide substantial improvements in pulmonary function with minimal toxicity (8) . In premature infants, serum concentrations of 6 to 11 mg/1 are necessary to control apnoeic spells (11) .
The present study presents an evaluation of an homogeneous enzyme immunoassay for the determination of theophylline (16) , mechanized by means of an Eppendorf analyzer 5010.
Material and Methods
Origin of specimens Serum samples (n = 130) containing theophylline were obtained from patients with obstructive lung disease. If theophylline was administered by intravenous infusion, blood samples were drawn from the cubital vein of the contralateral arm. During oral maintenance therapy blood specimens were taken as recom-0340-076X/79/0299-0302S2.00mended (7) either prior to the next dose or 2-4 hours afterwards.
Materials
The reagents for the enzyme immunoassay (EMIT), ammonium sulfate, chloroform, hexane, caffeine, xanthine, hypoxanthine, xanthosine, uric acid and urea were obtained from E. Merck 
Enzyme immunoassay (EMIT)
The original procedure of the EMIT theophylline assay was fully mechanized by adapting this test to the Eppendorf analyzer 5010 (Eppendorf, D-2000 Hamburg) in the same way as previously described for the EMIT phenobarbital and phenytoin assays (1).
Ultraviolet spectrophotometry Ultraviolet spectrophotometry of theophylline in serum was performed by a procedure discribed by Schwertner et al (17) using a DMR 21 double beam recording spectrophotometer (C. Zeiss, D-7082 Oberkochen).
Substrate determinations
Creatinine was measured in serum after tungstate precipation of protein and a Fuller's earth adsorption procedure (18) . Uric acid was determined by the aldehyde dehydrogenase method (19) (Human GmbH, D-6204 Taunusstein, cat. No H 1001) using an Abbott Dichromatic analyzer ABA-100.
Results and Discussion

Precision
The coefficients of variation from day to day were 5-6% with EMIT, and 6-12% with ultraviolet spectrophotometry (tab. 1). These precision data refer to mean values of duplicate determinations.
Tab. 1. The precision from day to day of EMIT and an ultraviolet spectrophotometric method for the determination of theophylline in serum. Assays were performed in duplicates on various days as indicated, and the mean values were used for calculation of the precision. The results for the recovery of theophylline by EMIT are shown in table 2. The recovery of theophylline added to drug-free pooled human serum ranged from 97-102%.
Furthermore the theophylline concentration was measured by EMIT and ultraviolet spectrophotometry in serum samples from 130 patients. However in nine of these specimens the theophylline concentration could not be determined by the ultraviolet method as the uv spectra were distorted by extraneous overlapping peaks due to interfering substances.
In a further 21 samples the theophylline concentration could not be measured by EMIT as it was below 2.5 mg/1. In three of these cases the uv method, however, gave theophylline values between 3.6 and 8.0 mg/1 presumably due to interference of proxyphylline and/or salbutamol. The absorption maximum of proxyphylline (273 nm) and salbutamol (276 nm) is very close to that of theophylline (274 nm).
The least-squares regression analysis of the results obtained with the remaining 100 serum samples showed the slope of the line to be 1.01 ( fig. 1 ). Deviations of more than 30% between the results determined by EMIT and ultraviolet spectrophotometry occurred with 8 out of these 100 samples. In five of these cases the discrepancies were reproducible. With four of these specimens the uv method yielded higher results than EMIT. These samples were obtained from patients who received salbutamol, 0-hydroxyethyltheophylline, trimethoprim and sulfamethoxazole in addition to theophylline. These substances show absorption maxima between 257 and 276 nm, which are near to that of theophylline. Therefore it appears, that these compounds caused the deviations observed by an interference in the uv-method. With only one of these five samples the uv-method yielded a lower result than EMIT.
Our results are in agreement with the reported satisfactory correlation of EMIT with ultraviolet spectrophotometric methods (20) (21) (22) , high pressure liquid chromatography (21-23) and radioimmunoassay (22) .
Tab. 3. Cross-reactivity of various substances in serum 3 ) with the EMIT theophylline assay.
> 500 Paraxanthine (1,7-dimethylxanthine) > 500 Caffeine (1,3,7-trimethylxanthine) > 500 l,3-dimethyl-xanthine-7-acetic 7-(^-dimethyl-aminoethoxy)-flavone > 500 7-(0-Hydioxyethyl)-! ,3-dimethylxanthine > 5 00 Diprophylline (7-(2,3-Dihydroxypropyl)-l,3-dimethylxanthine) > 500 Proxyphylline (7-(2-Hydroxypropyl)-l,3-dimethylxanthine) > 500 Xanthine > 500 Hypoxanthine > 500 Xanthosine > 500 Uric acid > 500 Urea > 5000 Phenobarbital > 500 Phenytoin > 500 Terbutaline > 500 Salbutamol > 500 Allopurinol > 500 Sulphamethoxazole > 500
?) substances were added to drug-free pooled human serum. ) concentrations exerting an absorbance equivalent to 2.5 mg/1 tfieophylline.
Specificity
The specificity of the EMIT assay was tested by the determination of the cross-reactivity of drugs structurally related to theophylline and various other compounds. The EMIT assay appeared to be highly specific, as none of the substances tested (tab. 3) showed a noticeable cross-reaction. According to the manufacturer's crossreactivity list (24) the major known metabolites of theophylline (25), 1,3-dimethyluric acid, 3-methylxanthine and 1-methyluric acid do not significantly cross react in this assay. Of the two further possible metabolites, 3-methyluric acid and 1-methykanthine, only the latter showed a marked cross reaction at concentrations above 10 mg/1 (24).
No positive results were obtained with serum samples from patients (n = 20) with renal insufficiency, receiving drugs other than theophylline (tab. 4).
Interferences
Bilirubin concentrations up to 600 μϊηοΐ/ΐ and haemogjobiri concentrations up to 10 g/1 did not affect the results of this assay. Triglyceride concentrations up to 4.0 mmpl/1 showed no interference.
Practicability and costs
The EMIT assay has the advantage that it can be easily mechanized. Adaptations to various analyzers such as the Abbott Bichromatic Analyzer (ABA 100) (21), Rotochem II (26) ) n = number of specimens per series ) costs per minute technician time 0.60 DM (27) .
takes about 40 minutes, as a new calibration curve has to be prepared with every run. ·
The costs for a theophylline determination including standards, control sera, reagents, pertinent supplies and technician time are about 21 DM per EMIT test and about 19 DM with the uv-method, for a series of 10 samples (duplicate determinations). A single theophylline determination is much more expensive (tab. 5).
Conclusion
Compared with the ultraviolet spectrophotometric method, the EMIT theophylline assay showed a distinctly better specificity and practicability. Furthermore the EMIT assay could be easily mechanized and proved to be rapid and reliable. The results of our study showed the EMIT technique to be well suited for monitoring serum theophylline levels.
